RecruitingNCT06036719
Rare condition
Acute interstitial pneumonia
2
studies recruiting now
as of 7 Sept 2026
42
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
14 Sept 2023
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT05681962
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Acute interstitial pneumonia studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Acute interstitial pneumonia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Acute interstitial pneumonia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
51 approved treatments and 77 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Garenoxacin MesylateApproved: Cefotaxime Sodium (Cefcil)Approved: LascufloxacinApproved: Ascorbic Acid (Ascor)Approved: Cilastatin Sodium (Cilastatin sodium component of mk-7655a)Approved: PiperacillinApproved: Moxifloxacin Hydrochloride (Avelox)Approved: Levofloxacin (Evoxil)Approved: Foscarnet Sodium (Foscarnet sodium)Approved: Hydrocortisone (Acetasol hc)Approved: Telithromycin (Ketek)Approved: Imipenem (Imipenem component of primaxin)Approved: Ceftaroline Fosamil Acetate (Zinforo)Approved: Clindamycin Hydrochloride (Cleocin)Approved: Ceftazidime (Ceftazidime)Approved: Cefdinir (Cefdinir)Approved: Cefoxitin Sodium (Mefoxin)Approved: Metronidazole (Acea)Approved: Azithromycin (Azasite)Approved: Vaborbactam (Vaborbactam component of carbavance)Approved: Cefaclor (Bacticlor mr)Approved: Methylprednisolone (Medrol)Approved: Pentamidine Isethionate (Nebupent)Approved: Cefepime Hydrochloride (Cefepime hydrochloride)Approved: ArbekacinApproved: Piperacillin Sodium (Piperacillin sodium component of zosyn)Approved: Bacitracin (Albac 50)Approved: Aztreonam (Azactam)Approved: Dexamethasone Sodium Phosphate (Ak-dex)Approved: Cortisone Acetate (Cortate)Approved: Amoxicillin SodiumApproved: Avibactam (Avibactam component of zavicefta)Approved: Clarithromycin (Biaxin)Approved: SitafloxacinApproved: TosufloxacinApproved: Tebipenem Pivoxil (Orapenem)Approved: Prednisone (Cortan)Approved: Clavulanate Potassium (Clavulanate potassium component of augmentin)Approved: Streptomycin Sulfate (Streptomycin sulfate)Approved: Tazobactam Sodium (Tazobactam sodium component of zerbaxa)Approved: Dexamethasone (Aeroseb-dex)Approved: Clindamycin Phosphate (Cleocin)Approved: TazobactamApproved: Linezolid (Linezolid)Approved: Prednisolone (Cortalone)Approved: Doxycycline (Doxirobe)Approved: Cefuroxime Sodium (Britacef)Approved: Vancomycin Hydrochloride (Firvanq kit)Approved: Amoxicillin (Amix 125)Approved: Avibactam Sodium (Avibactam sodium component of avycaz)Approved: Meropenem (Meropenem)
Phase 3Heparin
Phase 3Chlorhexidine Gluconate (Acriflex)
Phase 3Omadacycline
Phase 3Canakinumab (Ilaris)
Phase 3Zinc Acetate Anhydrous (Zinc acetate anhydrous component of nano-dtpa capsule zinc acetate)
Phase 3Tedizolid Phosphate (Sivextro)
Phase 3Chlorhexidine
Phase 3Penicillin G Potassium (Cilloral)
+ 69 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).